Osmotica Pharmaceutical is a global pharmaceutical company specializing in drug delivery technologies and neurology based therapies. The Company has a portfolio of products in various stages of development focused in the treatment of Parkinson's disease. In addition, the Company utilizes its well established drug delivery technologies (including its Osmodex® technologies) and its expertise to develop drug candidates for partner companies. Osmotica has a track record of successfully developing and commercializing products in the US, Europe and other countries around the world.
Osmotica is an international group of companies with principal operations located in the United States, Argentina and Osmotica Kft in Hungary. Osmotica manufactures its products in the U.S., Argentina and Spain.